Director

• Execute on the HEOR plan by designing, developing, and completing HEOR-led studies that support commercialization strategies and demonstrate value to key stakeholders
• Lead development of AMCP Dossiers, Budget Impact Models and other economic tools to support the commercialization of BridgeBio therapies
• Collaborate with KOLs on study design and authorship to execute HEOR studies and build relationships with Centers of Excellence
• Support US field team with engagement with payers and population health decision makers to demonstrate the value of BridgeBio therapies to inform decisions on utilization
• Partner with Clinical Development, Evidence Generation and Statistics colleagues on the design and execution of HEOR studies including real world evidence for BridgeBio therapies
• Conduct HEOR advisory boards and market research as needed to understand evolving evidence requirements for payers and IDNs in assigned therapeutic areas
• Collaborate with Head of HEOR and Market Access colleagues in ICER assessments and responses related to assigned therapeutic areas

US Director – Health Economics & Outcomes Research

Franchisee, Fractional C-Suite, Part-Time Director

Associate Director, Clinical Pharmacology Lead

Patient Access Director, Primary Care

Primary Care MGT Patient Access Director – Secondment

Senior Director, Warehouse Management Technologies